login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
HEALTHEQUITY INC (HQY) Stock News
USA
- NASDAQ:HQY -
US42226A1079
-
Common Stock
100.71
USD
+7 (+7.47%)
Last: 11/10/2025, 3:48:43 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
HQY Latest News, Press Relases and Analysis
All
Press Releases
19 days ago - By: Chartmill
HEALTHEQUITY INC (NASDAQ:HQY) Presents a Compelling Growth and Breakout Opportunity
5 days ago - By: HealthEquity, Inc.
HealthEquity Announces Third Quarter Earnings Date
6 days ago - By: Zacks Investment Research
Why HealthEquity (HQY) is a Top Growth Stock for the Long-Term
10 days ago - By: Zacks Investment Research
- Mentions:
BSX
DXCM
SOLV
DexCom Stock Falls Despite Q3 Earnings Beat, 2025 Revenue View Raised
11 days ago - By: Zacks Investment Research
- Mentions:
BSX
OPK
SOLV
OPK Q3 Earnings Beat Estimates, Sales Miss, Gross Margin Expands
11 days ago - By: Zacks Investment Research
- Mentions:
BSX
GKOS
SOLV
GKOS Stock Surges Following Q3 Earnings & Revenue Beat, Guidance Raised
11 days ago - By: Zacks Investment Research
- Mentions:
BSX
BAX
SOLV
BAX Stock Falls Following Q3 Earnings Beat & Sales Miss, '25 EPS View Down
11 days ago - By: Zacks Investment Research
- Mentions:
BSX
CAH
SOLV
CAH Q1 Earnings Beat Estimates, '26 EPS View Up, Stock Gains
14 days ago - By: Benzinga
How Do Investors Really Feel About HealthEquity Inc?
21 days ago - By: Zacks Investment Research
- Mentions:
CI
HIMS
LFMD
HQY Expands Access With GLP-1 Telehealth & Direct HSA Platforms
a month ago - By: Zacks Investment Research
HealthEquity (HQY) Down 5.1% Since Last Earnings Report: Can It Rebound?
a month ago - By: Benzinga
How Do Investors Really Feel About HealthEquity Inc?
2 months ago - By: HealthEquity, Inc.
HealthEquity Strengthens Executive Leadership Team with Strategic Appointments to Drive Growth and Innovation
2 months ago - By: Zacks Investment Research
Why HealthEquity (HQY) is a Top Growth Stock for the Long-Term
2 months ago - By: Zacks Investment Research
- Mentions:
BSX
WST
MEDP
HealthEquity Stock Gains as Q2 Earnings Beat Estimates, Revenues Up Y/Y
2 months ago - By: The Motley Fool
HealthEquity Net Income Jumps 67% in Q2
2 months ago - By: Zacks Investment Research
Compared to Estimates, HealthEquity (HQY) Q2 Earnings: A Look at Key Metrics
2 months ago - By: Zacks Investment Research
- Mentions:
PACS
HealthEquity (HQY) Q2 Earnings and Revenues Surpass Estimates
2 months ago - By: HealthEquity, Inc.
HealthEquity Reports Second Quarter Ended July 31, 2025 Financial Results
2 months ago - By: HealthEquity, Inc.
HealthEquity's AI-Powered Tool Recognized for Innovation in Streamlining Benefits Education
3 months ago - By: Zacks Investment Research
- Mentions:
CVS
CVS vs. HQY: Which Stock Is the Better Value Option?
3 months ago - By: Zacks Investment Research
Countdown to HealthEquity (HQY) Q2 Earnings: A Look at Estimates Beyond Revenue and EPS
3 months ago - By: Zacks Investment Research
- Mentions:
RNXT
RenovoRx, Inc. (RNXT) Reports Q2 Loss, Tops Revenue Estimates
3 months ago - By: Zacks Investment Research
- Mentions:
BSX
WST
MEDP
Reasons to Hold HealthEquity Stock in Your Portfolio for Now
3 months ago - By: Zacks Investment Research
- Mentions:
IRD
Opus Genetics, Inc. (IRD) Reports Q2 Loss, Lags Revenue Estimates
Please enable JavaScript to continue using this application.